Genetic retargeting of adenovirus vectors: Functionality of targeting ligands and their influence on virus viability

Journal of Gene Medicine

Volumn 4, Issue 4, 2002, Pages 356-370

  Magnusson, Maria K ^a,b   Hong, Saw See ^c   Henning, Petra ^a,b   Boulanger, Pierre ^c   Lindholm, Leif ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Got A Gene AB   (Sweden)

^c UNIVERSITÉ DE LYON   (France)

Author keywords

Ad5 vectors; Cell targeting; Fiber gene; Fiber solubility; Protein folding; Virus viability

Indexed keywords

ADENOVIRUS VECTOR; CELL SURFACE PROTEIN; EPIDERMAL GROWTH FACTOR; HYBRID PROTEIN; LIGAND; POLYPEPTIDE; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; IMMUNOGLOBULIN FRAGMENT;

ADENOVIRUS 5; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; GENE CONSTRUCT; GENE FUNCTION; GENE NUMBER; GENE TARGETING; GROWTH RATE; MOLECULAR CLONING; NONHUMAN; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FOLDING; SOLUBILITY; VIRAL GENE DELIVERY SYSTEM; VIRION; VIROGENESIS; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS RECOMBINANT; ADENOVIRUS; ANIMAL; CELL STRAIN COS1; FLUORESCENT ANTIBODY TECHNIQUE; GENE TRANSFER; GENE VECTOR; GENETICS; HUMAN;

ADENOVIRIDAE; ANIMALS; COS CELLS; FLUORESCENT ANTIBODY TECHNIQUE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; IMMUNOGLOBULIN FRAGMENTS; LIGANDS;

EID: 0036634563     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.285     Document Type: Article

References (50)

1. Boon T. van der Bruggen P. Human tumor antigens recognized by T lymphocytes. J Exp Med 1996; 183: 725-729.
2. Israeli RS, Powell CT, Corr JG, et al. Expression of the prostate-specific membrane antigen. Cancer Res 1994; 54: 1807-1811.
3. Weiner LM. An overview of monoclonal antibody therapy of cancer. Semin Oncol 1999; 26(4 Suppl 12): 41-50.
4. Mountain A. Gene therapy: the first decade. Trends Biotechnol 2000; 18: 119-128.
5. Bergelson JM, Cunningham JA, Droguett G, et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320-1323.
6. Hong SS, Karayan L, Tournier J, et al. Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells. Embo J 1997; 16: 2294-2306.
7. Dechecchi MC, Melotti P, Bonizzato A, et al. Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5. J Virol 2001; 75 8772-8780.
8. Chroboczek J, Ruigrok RW, Cusack S. Adenovirus fiber. Curr Top Microbiol Immunol 1995; 199: 163-200.
9. Hong JS, Engler JA. The amino terminus of the adenovirus fiber protein encodes the nuclear localization signal. Virology 1991; 185: 758-767.
10. Hong JS, Engler JA. Domains required for assembly of adenovirus type 2 fiber trimers. J Virol 1996; 70: 7071-7078.
11. Louis N, Fender P, Barge A, et al. Cell-binding domain of adenovirus serotype 2 fiber. J Virol 1994; 68: 4104-4106.
12. Mullis KG, Haltiwanger RS, Hart GW, et al. Relative accessibility of N-acetylglucosamine in trimers of the adenovirus types 2 and 5 fiber proteins. J Virol 1990; 64: 5317-5323.
13. Magnusson M, Hong S, Boulanger P, et al. Genetic retargeting of adenovirus: novel strategy employing "deknobbing:of the fiber. J Virol 2001; 75: 7280-7289.
14. Graham F, Smiley J, Russell W, et al. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977; 36: 59-74.
15. Suarez Pestana E, Tenev T, Gross S, et al. The transmembrane protein tyrosine phosphatase RPTPsigma modulates signaling of the epidermal growth factor receptor in A431 cells. Oncogene 1999; 18: 4069-4079.
16. Willemsen RA, Weijtens ME, Ronteltap C, et al. Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR. Gene Ther 2000; 7: 1369-1377.
17. Uemura H, Okajima E, Debruyne FM, et al. Internal image anti-idiotype antibodies related to renal-cell carcinoma-associated antigen G250. Int J Cancer 1994; 56: 609-614.
18. Rogers BE, Douglas JT, Ahlem C, et al. Use of a novel crosslinking method to modify adenovirus tropism. Gene Ther 1997; 4: 1387-1392.
19. Hoppe HJ, Barlow PN, Reid KB. A parallel three stranded alphahelical bundle at the nucleation site of collagen triple-helix formation. FEBS Lett 1994; 344: 191-195.
20. Pasqualini R, Koivunen E, Ruoslahti E. Alpha v integrins as receptors for tumor targeting by circulating ligands. Nat Biotechnol 1997; 15: 542-546.
21. Urdea MS, Merryweather JP, Mullenbach GT, et al. Chemical synthesis of a gene for human epidermal growth factor urogastrone and its expression in yeast. Proc Natl Acad Sci U S A 1983; 80: 7461-7465.
22. Oosterwijk E, Ruiter DJ, Hoedemaeker PJ, et al. Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney. Int J Cancer 1986; 38 489-494.
23. Johansson C. C242 and other monoclonal antibodies defining novel human colrectal carcinoma associated epitopes. A study with special reference to specificity and possible clinical utility. Department of Medical Microbiology and Immunology, University of Göteborg: Göteborg, 1991.
24. Weijtens ME, Willemsen RA, Valerio D, et al. Single chain Ig/gamma gene-redirected human T lymphocytes produce cytokines, specifically lyse tumor cells, and recycle lyric capacity. J Immunol 1996; 157: 836-843.
25. Tang Y, Jiang N, Parakh C, et al. Selection of linkers for a catalytic single-chain antibody using phage display technology. J Biol Chem 1996; 271: 15682-15686.
26. Novelli A, Boulanger PA. Deletion analysis of functional domains in baculovirus-expressed adenovirus type 2 fiber. Virology 1991; 185: 365-376.
27. Chartier C, Degryse E, Gantzer M, et al. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol 1996; 70: 4805-4810.
28. Oliner J, Kinzler K, Vogelstein B. In vivo cloning of PCR products in E. coli. Nucleic Acids Res 1993; 21: 5192-5197.
29. He TC, Zhou S, da Costa LT, et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 1998; 95: 2509-2514.
30. Ebbinghaus SW, Vigneswaran N, Miller CR, et al. Efficient delivery of triplex forming oligonucleotides to tumor cells by adenovirus-polylysine complexes. Gene Ther 1996; 3: 287-297.
31. O'Reilly D, Miller L, Luckow V. Baculovirus Expression Vectors: a Laboratory Manual. Oxford University Press: New York, 1994.
32. Green M, Pina M, Kimes RC. Biochemical studies on adenovirus multiplication. XII. Plaquing efficiencies of purified human adenoviruses. Virology 1967; 31: 562-565.
33. Caillet-Boudin ML, Lemay P, Boulanger P. Functional and structural effects of an Ala to Val mutation in the adenovirus serotype 2 fibre. J Mol Biol 1991; 217: 477-486.
34. Santis G, Legrand V, Hong S, et al. Molecular determinants of adenovirus serotype 5 fibre binding to its cellular receptor CAR. J Gen Viral 1999; 80: 1519-1527.
35. Karayan L, Gay B, Gerfaux J, et al. Oligomerization of recombinant penton base of adenovirus type 2 and its assembly with fiber in baculovirus-infected cells. Virology 1994; 202: 782-795.
36. Duque PM, Alonso C, Sanchez-Prieto R, et al. Adenovirus lacking the 19-kDa and 55-kDa E1B genes exerts a marked cytotoxic effect in human malignant cells. Cancer Gene Ther 1999; 6: 554-563.
37. Shayakhmetov DM, Lieber A. Dependence of adenovirus infectivity on length of the fiber shaft domain. J Virol 2000; 74: 10274-10286.
38. van Beusechem VW, van Rijswijk AL, van Es HH, et al. Recombinant adenovirus vectors with knobless fibers for targeted gene transfer. Gene Ther 2000; 7: 1940-1946.
39. Krasnykh V, Belousova N, Korokhov N, et al. Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin. J Virol 2001; 75: 4176-4183.
40. Biocca S, Ruberti F, Tafani M, et al. Redox state of single chain Fv fragments targeted to the endoplasmic reticulum, cytosol and mitochondria. Biotechnology (N Y) 1995; 13: 1110-1115.
41. Glockshuber R, Schmidt T, Pluckthun A. The disulfide bonds in antibody variable domains: effects on stability, folding in vitro, and functional expression in Escherichia coli. Biochemistry 1992; 31 1270-1279.
42. Cattaneo A, Biocca S. The selection of intracellular antibodies. Trends Biotechnol 1999; 17: 115-121.
43. Pecorari F, Tissot AC, Pluckthun A. Folding, heterodimeric association and specific peptide recognition of a murine alphabeta T-cell receptor expressed in Escherichia coli. J Mol Biol 1999; 285: 1831-1843.
44. Dmitriev I, Krasnykh V, Miller CR, et al. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J Virol 1998; 72: 9706-9713.
45. Staba MJ, Wickham TJ, Kovesdi I, et al. Modifications of the fiber in adenovirus vectors increase tropism for malignant glioma models. Cancer Gene Ther 2000; 7: 13-19.
46. Koivunen E, Wang B, Ruoslahti E. Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins. Biotechnology (N Y) 1995; 13: 265-270.
47. Legrand V, Spehmer D, Schlesinger Y, et al. Fiberless recombinant adenoviruses: virus maturation and infectivity in the absence of fiber. J Virol 1999; 73: 907-919.
48. Chiu CY, Wu E, Brown SL, et al. Structural analysis of a fiber-pseudotyped adenovirus with ocular tropism suggests differential modes of cell receptor interactions. J Virol 2001; 75: 5375-5380.
49. Nygren PA, Uhlen M. Scaffolds for engineering novel binding sites in proteins. Curr Opin Struct Biol 1997; 7: 463-469.
50. Nord K, Gunneriusson E, Ringdahl J, et al. Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain. Nat Biotechnol 1997; 15: 772-777.